# Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
Canonical URL: https://biopharmsignal.com/news/ASRT/assertio-to-participate-in-the-maxim-group-healthcare-virtual-summit-on-october--506469bc
Ticker: ASRT
Company: Assertio
Source: Assertio
Published: 2024-10-11 12:00 EST
## Summary

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with...

## Article Body
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Brendan O’Grady, Chief Executive Officer, will participate in a fireside chat discussion as part of the Maxim Group 2024 Healthcare Virtual Summit. The fireside chat with Mr. O’Grady, hosted by Maxim Group research analyst Naz Rahman, will occur Tuesday, October 15, 2024 at 1:00 pm Eastern Time.

Investors can register to listen to the event via https://m-vest.com/events/healthcare-10152024 .

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com .

Investor Contact

Matt Kreps, Managing Director Darrow Associates M: 214-597-8200 mkreps@darrowir.com
## Recent Company News
- 2025-10-28 13:15 EST — [Assertio Announces Leadership Transition](https://biopharmsignal.com/news/ASRT/assertio-announces-leadership-transition-13208d9d) — Source: Assertio
- 2025-09-15 13:00 EST — [Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV](https://biopharmsignal.com/news/ASRT/assertio-presents-first-ever-real-world-study-showing-patient-experience-with-sy-14523696) — Source: Assertio
- 2025-09-10 11:30 EST — [Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association](https://biopharmsignal.com/news/ASRT/assertio-to-present-new-data-from-real-world-evidence-study-of-sympazan-at-upcom-a319cbba) — Source: Assertio
- 2025-09-03 12:15 EST — [Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025](https://biopharmsignal.com/news/ASRT/assertio-to-participate-in-the-hc-wainwright-and-lake-street-conferences-in-sept-8cca2126) — Source: Assertio
- 2025-08-11 20:05 EST — [Assertio Reports Second Quarter 2025 Financial Results](https://biopharmsignal.com/news/ASRT/assertio-reports-second-quarter-2025-financial-results-d87a0872) — Source: Assertio
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)